Literature DB >> 12631015

Phototherapeutic keratectomy: 12 years of experience.

Per Fagerholm1.   

Abstract

BACKGROUND: Phototherapeutic keratectomy (PTK) has been employed as a surgical tool to treat corneal disease for more than 10 years. The laser has made it possible to remove superficial corneal opacities and thereby restore vision. The 193 nm ultraviolet light separates molecules and splits molecules in biological tissue, thereby ablating it. About 0.25 microm of tissue is ablated by each pulse. The development of the excimer laser technique has been fast. It has principally focused on refractive surgery but has also benefited PTK. CORNEAL DYSTROPHIES: The ability to delay or postpone corneal grafting in superficial corneal dystrophies represents a very important achievement. Map-dot-fingerprint dystrophy or basal membrane dystrophy is a common indication for PTK. Other dystrophies such as Meesman's, Reis-Bückler's, Thiel-Benke's, granular, macular, lattice and Schnyder's can be treated, although with differing degrees of success and varying rates of recurrence. Subepithelial scarring in Fuchs' dystrophy has been ablated. Other trials have involved the removal of substantial parts of the stroma in order to reduce the load on the endothelium. Recurrent dystrophic changes can likewise be removed from corneal grafts and thus prevent the need for regrafting. RECURRENT EROSIONS: Laser treatment has made it possible to manage wound-healing problems better after recurrent erosions. Recurrent erosions are the most common indications for PTK: several studies show good and persistent effects with this type of treatment. Persistent epithelial defects of various origins, among them corneal ulcers resulting from allergic disease, can likewise be treated. SCAR TISSUE: Scars after surgery such as pterygeum excision can be removed. Smooth muscle actin containing fibroblasts in old scars should be given special consideration in PTK. Excimer laser surgery can be successfully combined with conventional surgery to remove excessive scar tissue, Salzmann's nodules and very flaky and coarse band keratopathy. Irregular corneal surfaces following ulcers and injuries pose problems that have so far proved difficult to overcome. Thinning is often seen after bacterial corneal ulcers or after herpes simplex keratitis. A rough or uneven surface can be made smoother by using modulators during treatment by casting a new surface under a hard contact lens (PALM technique), a surface that is then projected into the stroma by laser ablation. Modern techniques linking the excimer laser with computerized corneal topography and wavefront analysis promise to further improve the smoothing capacities of lasers and to increase the quality of optical results. COMPLICATIONS: The most feared complication of PTK is the postoperative infection. These are rare. Haze is usually not prominent but scar tissue formation of a more persistent type has been noted after laser surgery in eyes with pre-existing surgical scars. Keratectasia has been described after PTK. Failure due to deep opacities or a surface that is too uneven is a more common frustration. This paper reviews advances in excimer laser treatment of corneal disease.

Entities:  

Mesh:

Year:  2003        PMID: 12631015     DOI: 10.1034/j.1600-0420.2003.00015.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  27 in total

Review 1.  [Phototherapeutic keratectomy. Undesirable effects, complications, and preventive strategies].

Authors:  G Geerling; W Sekundo
Journal:  Ophthalmologe       Date:  2006-07       Impact factor: 1.059

2.  Phototherapeutic keratectomy (PTK) for treatment of recurrent corneal erosion: Correlation between etiology and prognosis - prospective longitudinal study.

Authors:  Wasiliki Dedes; Livia Faes; Isaak Schipper; Lucas M Bachmann; Michael A Thiel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-04-22       Impact factor: 3.117

3.  Predictability of intraocular lens power calculation in eyes after phototherapeutic keratectomy.

Authors:  Ryo Yoneyama; Kazutaka Kamiya; Kei Iijima; Masahide Takahashi; Nobuyuki Shoji
Journal:  Jpn J Ophthalmol       Date:  2019-11-05       Impact factor: 2.447

4.  Superficial keratectomy, PTK, and mitomycin C as a combined treatment option for Salzmann's nodular degeneration: a follow-up of eight eyes.

Authors:  Riad Khaireddin; Toam Katz; Rahul B Baile; Gisbert Richard; Stephan J Linke
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-04-05       Impact factor: 3.117

5.  Fibril Core of Transforming Growth Factor Beta-Induced Protein (TGFBIp) Facilitates Aggregation of Corneal TGFBIp.

Authors:  Charlotte S Sørensen; Kasper Runager; Carsten Scavenius; Morten M Jensen; Nadia S Nielsen; Gunna Christiansen; Steen V Petersen; Henrik Karring; Kristian W Sanggaard; Jan J Enghild
Journal:  Biochemistry       Date:  2015-05-06       Impact factor: 3.162

6.  Central islands: rate and effect on visual recovery after phototherapeutic keratectomy.

Authors:  Atsufumi Hashimoto; Kazutaka Kamiya; Kimiya Shimizu; Akihito Igarashi; Hidenaga Kobashi
Journal:  Jpn J Ophthalmol       Date:  2015-08-20       Impact factor: 2.447

7.  Visual morbidity in thirty-four families with Schnyder crystalline corneal dystrophy (an American Ophthalmological Society thesis).

Authors:  Jayne S Weiss
Journal:  Trans Am Ophthalmol Soc       Date:  2007

8.  Recurrence rate and subjective symptoms after standardized (Hamburg protocol) phototherapeutic keratectomy on recurrent corneal erosions.

Authors:  J Mehlan; J Steinberg; L Traber; T Katz; S J Linke
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-08-22       Impact factor: 3.117

9.  Macular corneal dystrophy: mutational spectrum in German patients, novel mutations and therapeutic options.

Authors:  Claudia Gruenauer-Kloevekorn; Saskia Braeutigam; Wolfram Heinritz; Ursula G Froster; Gernot I W Duncker
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-05-24       Impact factor: 3.117

10.  Surgical outcome after phototherapeutic keratectomy in patients with TGFBI-linked corneal dystrophies in relation to molecular genetic findings.

Authors:  Claudia Gruenauer-Kloevekorn; Saskia Braeutigam; Ursula G Froster; Gernot I W Duncker
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-09-06       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.